Government ❯ Regulation ❯ FDA

Drug Approval Process

Clinical Trials Biologics License Application Counterfeit Drug Enforcement Drug Shortage Management Elevidys Clinical Holds Voluntary Hold Agency Oversight New Drug Application Orforglipron Approval Vaccine Approval Moderna Application Public Health Public Health Policy MDMA Therapy Placebo-Controlled Studies Quality Control

uniQure Soars 36% After FDA Biologics Chief Vinay Prasad Announces April Exit

Prasad’s planned departure is prompting investors to bet on a more flexible review path for uniQure’s Huntington’s gene therapy.

FDA Demands Placebo-Controlled Trial for UniQure’s Huntington’s Gene Therapy

Gym-Goers Turn From Steroids to Peptide Injections

Lilly’s Daily Obesity Pill Sustains Weight Loss After Switch From Wegovy or Zepbound

FDA Setback Puts uniQure’s Huntington’s Gene Therapy Filing in Doubt

FDA Accepts Replimune’s Resubmitted RP1 Melanoma Filing, Sets April 2026 Decision